L
Luke Boulanger
Researcher at Pfizer
Publications - 48
Citations - 1362
Luke Boulanger is an academic researcher from Pfizer. The author has contributed to research in topics: Population & Duloxetine. The author has an hindex of 21, co-authored 47 publications receiving 1291 citations.
Papers
More filters
Journal ArticleDOI
Potential Short-Term Economic Benefits of Improved Glycemic Control: A managed care perspective
TL;DR: In typical practice, better glycemic control is associated with a reduced rate of admission for selected short-term complications and, therefore, reduced medical charges for these complications over a 3-year period.
Journal ArticleDOI
Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program.
TL;DR: Compared with patients who received conventional antipsychotics, those receiving atypical antipsychotic medications were significantly less likely to have a switch in medication and to use concomitant anticholinergic and anxiolytic medications.
Journal ArticleDOI
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Joseph Menzin,Luke Boulanger,Jeno P. Marton,Lisa Guadagno,Homa Dastani,Riad Dirani,Amy L. Phillips,Hemal Shah +7 more
TL;DR: In this U.S. Medicare managed care population, COPD posed a substantial burden in terms of both respiratory-related and total healthcare costs.
The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare
Joseph Menzin,Luke Boulanger,Jeno P. Marton,Lisa Guadagno,Homa Dastani,Riad Dirani,Amy L. Phillips,Hemal Shah +7 more
TL;DR: In this paper, the authors used administrative claims and eligibility records from a large U.S. multi-state Medicare managed care database to estimate the excess costs of COPD among older adults.
Journal ArticleDOI
Quality of Anticoagulation Control and Costs of Monitoring Warfarin Therapy among Patients with Atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study
Joseph Menzin,Luke Boulanger,Ole Hauch,Mark Friedman,Cheryl Beadle Marple,Gail Wygant,Judith S. Hurley,Stephen Pezzella,Scott Kaatz +8 more
TL;DR: In 3 geographically diverse health plans, anticoagulation clinics provided a generally higher quality of control than previously reported in other observational studies, and the costs of obtaining this level of control are highlighted.